近日 ， 美敦力 Medtronic 宣布任命 Dr. Gerald Denny 为其急性护理与监测业务 (Acute Care & Monitoring, ACM) 的首席医疗官 (Chief Medical Officer, CMO)，负责推动该业务在全球范围的医疗战略与临床支持。 # 人 物介绍 — D r. G e r a l d D e n n y Dr. Denny 在医学和医疗器械领域经验丰富。他之前服务于医疗器械与医疗服务公司 BD (Becton, Dickinson and Company) ，负责多个技术与业务线的医疗事务 (Medical Affairs)，涵盖泌尿、重症护理、智能连接医疗 (Smart Connected Care)、血管通路设备 (Vascular Access) 等领域。 在加入 Medtronic 之前，他还曾担任美国医疗评审机构 Medical Review Institute of America (MRIoA) 的首席 医疗官 (CMO) ，拥有丰富的医疗临床、管理与审查经验。 Dr. Denny 是肾内科与内科双重认证医生 (board-certifie ...

Core Insights - Medtronic has appointed Kate Benedict as the Senior Vice President and President of the Acute Care & Monitoring (ACM) division, which is part of its Medical Surgical Portfolio, effective June 10, 2025. Her extensive experience in the medical industry is expected to drive innovation and growth in this newly formed division [6][15]. Company Developments - Medtronic has undergone significant personnel changes in recent years, including the departure of key executives and the restructuring of its business units. The company announced in February 2024 that it would exit the unprofitable ventilator product line and merge its remaining patient monitoring and respiratory intervention businesses into the new ACM division [7][8]. - The ACM division is positioned to capitalize on a $100 billion market potential, focusing on hospital and home monitoring, particularly in chronic disease management and post-operative care [11][15]. Market Context - The demand for ventilators has sharply declined following the stabilization of the COVID-19 pandemic, leading to decreased profitability in this product line. Medtronic's strategic shift aims to focus on high-growth monitoring technologies [11][8]. - The ACM division's product offerings include pulse oximeters, remote patient monitoring, airway management, and respiratory monitoring products, which are essential for acute care, post-operative recovery, and chronic disease management [13][17]. Future Outlook - The appointment of Kate Benedict comes at a crucial time as the ACM division seeks new growth opportunities. Her cross-industry experience is anticipated to enhance the market expansion of products like HealthCast™ and Argos™ [11][15]. - Medtronic's revenue for the fiscal year 2024 was reported at $32.4 billion, with the Medical Surgical Portfolio, including ACM, accounting for approximately 26% of this total [11].

Core Viewpoint - Medtronic has appointed Kate Benedict as the Senior Vice President and President of the Acute Care & Monitoring (ACM) division, marking a strategic shift in response to market changes and aiming for growth in the healthcare sector [6][15]. Summary by Sections Appointment of Kate Benedict - Kate Benedict brings over 25 years of experience in the medical industry, with a focus on medical devices, diagnostics, pharmaceuticals, and drug delivery [4]. - She has held leadership roles at Flex, BD, Alcon, and Johnson & Johnson, demonstrating a strong background in driving innovation and market growth [5]. Recent Changes at Medtronic - Medtronic has undergone significant personnel changes, including the departure of key executives and the restructuring of its ACM division [7][8]. - The company decided to integrate its patient monitoring and respiratory intervention businesses into the new ACM division instead of divesting them, which had previously been valued at $9 billion [8][11]. Market Dynamics and Strategic Focus - The ACM market has seen substantial changes, particularly due to the decline in demand for ventilators post-COVID-19, prompting Medtronic to focus on high-growth monitoring technologies [11]. - The ACM division's product line includes pulse oximeters, remote patient monitoring, airway management, and respiratory monitoring products, aimed at meeting new market demands [11][13]. Financial Outlook - Medtronic's revenue for fiscal year 2024 was $32.4 billion, with the medical surgical portfolio, including ACM, accounting for approximately 26% of this revenue [11]. - The ACM division is positioned within a $100 billion market potential, particularly in chronic disease management and post-operative care, seen as a growth engine for the company [11]. Recent Developments - In April 2025, Medtronic entered a distribution agreement with Retia Medical to introduce the Argos™ cardiac output monitor, enhancing its monitoring capabilities in the ACM field [14].